Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma × futibatinib × Sarcoma × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasm Metastasis 2 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Sarcoma, Alveolar Soft Part 1 Sarcoma 1 Leiomyosarcoma 1 Histiocytoma, Malignant Fibrous 1 Head and Neck Neoplasms 1 Esophageal Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Biliary Tract Neoplasms 1

Interventions

Doxorubicin 124 Ifosfamide 72 Radiotherapy 67 Cyclophosphamide 62 Gemcitabine 54 Filgrastim 47 pazopanib 36 Trabectedin 36 Docetaxel 35 pembrolizumab 34 Etoposide 33 Vincristine 31 Cisplatin 30 Nivolumab 27 Magnetic Resonance Spectroscopy 23 Irinotecan 21 Radiation 20 Carboplatin 20 Surgical Procedures, Operative 19 Ipilimumab 19 Temozolomide 17 Biopsy 17 Bevacizumab 17 Mesna 16 Melphalan 16 Granulocyte Colony-Stimulating Factor 16 eribulin 15 Specimen Handling 15 Sirolimus 15 Drug Therapy 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03784014 2025-12-11

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Active not recruiting

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡